Effects of inhibitors of inflammatory mediators and cytokines on eosinophil and neutrophil accumulation induced by Mycobacterium bovis bacillus Calmette-Guerin in mouse pleurisy

Journal of Leukocyte Biology

Volumn 62, Issue 6, 1997, Pages 778-785

  Menezes De Lima Jr , Octávio ^a   Werneck Barroso, Eduardo ^a   Cordeiro, Renato S B ^b   Henriques, Maria Das Graças M O ^a,b  

^a Medicines and Drugs Technology Institute Fiocruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Inflammation; Interleukin 5; Leukotrienes; Nitric oxide; Platelet activating factor; Tumor necrosis factor

Indexed keywords

BCG VACCINE; CYTOKINE; INTERLEUKIN 5; LEUKOTRIENE; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; INTRAPLEURAL DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; MOUSE; MYCOBACTERIUM BOVIS; NEUTROPHIL; NONHUMAN; PLEURISY; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 2542545729     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.62.6.778     Document Type: Article

References (52)

1. Dannemberg, A. M., Jr. (1989) Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev. Infect. Dis. 2, 369-378.
2. Griffin, J. F. T., Markintosh, C. G., Buchan, G. S. (1995) Animal models of protective immunity in tuberculosis to evaluate candidate vaccines. Trends Microbiol. 3, 418-424.
3. Chrétien, J. (1995) Tuberculosis today. Eur. Resp. J. 8, 617s-619s.
4. Fenton, M. J., Vermeulen, M. W. (1996) Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64, 683-689.
5. Henriques, M. G. M. O. Weg, V. B., Martins, M. A., Silva, P. M. R., Fernandes, P. D., Cordeiro, R. S. B., Vargaftig, B. B. (1990) Differential inhibition by two hetrazepine PAK antagonists of acute inflammation in the mouse. Br. J. Pharmacol. 99, 164-168.
6. Schumacher, J. H., O'Garra, A., Shrader, B., Van-Kimmenade, A., Bond, M. W., Mosmann, T. R., Coffman, R. L. (1988) The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141, 1576-1581.
7. Appelberg, R. (1992) Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J. Leukoc. Biol. 52, 303-306.
8. Antony, V. B., Sahn, S. A., Antony, A. C., Repine, J. E. (1985) Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro. J. Clin. Invest. 76, 1514-1521.
9. Berger, H. W., Mejia, E. (1973) Tuberculous pleurisy. Chest 63, 88-92.
10. Vijayan, V. K., Rectha, A. M., Jawahar, M. S., Sankaran, K., Prabhakar, R. (1992) Pulmonary eosinophilia in pulmonary tuberculosis. Chest 101, 1708-1709.
11. Nakamura, Y., Ozaki, T., Kamei, T., Kawaji, K., Banno, K., Miki, S., Fujisawa, K., Yasuoka, S., Ogura, T. (1993) Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: Relationship to granulocyte-macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am. J. Respir. Cell Mol. Biol. 8, 605-611.
12. Castro, A. G., Esaguy, N., Macedo, P. M., Aguas, A. P., Silva, M. T. (1991) Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils in vivo and are ingested by the attracted granulocytes. Infect. Immun. 59, 3009-3014.
13. Bozza, P. T., Castro-Faria-Neto, H. C., Penido, C., Larangeira, A. P., Silva, P. M. R., Martins, M. A., Cordeiro, R. S. B. (1994) IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by LPS. Immunopharmacol. 27, 131-136.
14. Henriques, M. G. M. O., Miotla, J. M., Cordeiro, R. S. B., Wolitzky, B. A., Woolley, S. T., Hellewell, P. G. (1996) Selectins mediate eosinophil recruitment in vivo: A comparison with their role in neutrophil influx. Blood 87, 5297-5304.
15. 2 inhibitory protein which prevents prostaglandin generation. Nature 278, 456-459.
16. Lellouch-Tubiana, A., Lefort, J., Simon, M. T., Pfister, A., Vargaftig, B. B. (1988) Eosinophil recruitment into Guinea-pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion and selective antagonists. Am. Rev. Respir. Dis. 137, 948-955.
17. Wardlaw, A. J., Moqbel, R., Cromwell, O., Kay, A. B. (1986) Patelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78, 1701-1706.
18. Higgs, G. A., Follenfant, R. L., Garland, L. G. (1988) Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses. Br. J. Pharmacol. 94, 547-551.
19. Pasquale, C. P., Martins, M. A., Bozza, P. T., Silva, P. M. R., Castro-Faria-Neto, H. C., Pires, A. L., Cordeiro, R. S. B. (1991) Bradykinin induces eosinophil accumulation in the rat pleural cavity. Int. Arch. Allergy Appl. Immunol. 95, 244-247.
20. Silva, P. M. R., Martins, M. A., Lima, M. C. R., Alves, A. C., Dias, B. L., Cordeiro, R. S. B. (1992) Pharmacological modulation of the late eosinophilia induced by antigen in actively sensitized rats. Int. Arch. Allergy Appl. Immunol. 98, 355-360.
21. Bozza, P. T., Castro-Faria-Neto, H. C., Martins, M. A., Larangeira, A. P., Perales, J. E., Silva, P. M. R., Cordeiro, R. S. B. (1993) Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat: a role for a newly generated protein. Eur. J. Pharmacol. 248, 41-47.
22. Higgs, G. A., Eakins, K. E., Mugrige, K. G., Moncada, S., Vane, J. R. (1980) The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation. Eur. J. Pharmacol. 66, 81-86.
23. Salmon, J. A., Higgs, G. A. (1987) Prostaglandins and leukotrienes as inflammatory mediator. Br. Med. Bull. 43, 285-296.
24. Teixeira, M. M. Hellewell, P. G. (1994) Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig. Br. J. Pharmacol. 111, 1205-1211.
25. Henriques, M. G. M. O., Silva, P. M. R., Martins, M. A., Flores, C. A., Cunha, F. Q., Assreuy-Filho, J., Cordeiro, R. S. B. (1987) Mouse paw edema. A new model for inflammation? Braz. J. Med. Biol. Res. 20, 243-249.
26. Resnick, M. B., Weller, P. F. (1993) Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8, 349-355.
27. Casals-Stenzel, J., Muacevic, G., Weber, K. H. (1987) Pharmacological actions of WEB 2086, a new specific antagonist of platelet-activating factor. J. Pharmacol. Exp. Ther. 241, 974-981.
28. Heuer, H. O., Casals-Stenzel, J., Muacevic, G., Weber, K. H. (1900) Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet-activating factor. J. Pharmacol. Exp. Ther. 255, 962-968.
29. Martins, M. A., Castro-Faria-Neto, H. C., Bozza, P. T., Silva, P. M. R., Lima, M. C. R., Cordeiro, R. S. B., Vargaftig, B. B. (1993) Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats. J. Leukoc. Biol. 53, 104-111.
30. Seeds, E. A., Coyle, A. J., Page, C. P. (1991) The effect of the selective PAF antagonist WEB 2170 on PAF and antigen-induced airway hyperresponsiveness and eosinophil infltration. J. Lipid Mediat. 4, 111-121.
31. 4. Int. Arch. Allergy Appl. Immunol. 88, 191-193.
32. Martins, M. A., Silva, P. M. R., Castro-Faria-Neto, H. C., Bozza, P. T., Dias, P. M. F. L., Lima, M. C. R., Cordeiro, R. S. B., Vargaftig, B. B. (1989) Pharmacological modulation of PAF-induced rat pleurisy and its role in the inflammation by zymosan. Br. J. Pharmacol. 96, 363-371.
33. Silva, P. M. R., Martins, M. A., Castro-Faria-Neto, H. C., Cordeiro, R. S. B., Vargaftig, B. B. (1991) Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor injected rats. J. Pharmacol. Exp. Ther. 257, 1039-1044.
34. Nourshargh, S. (1993) Mechanisms of neutrophil and eosinophil accumulation in vivo. Am. Rev. Respir. Dis. 148, S60-S64.
35. Kaplan, S. S., Billar, T., Curran, R. D., Zdziraski, V. E., Simmons, R. L., Basford, R. E. (1989) Inhibition of chemotaxis with N-monomethyl L-arginine: a role for cyclic GMP. Blood 74, 1885-1902.
36. Belenky, S. N., Robbins, R. A., Rubinstein, I. (1993) Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leukoc. Biol. 498, 408-503.
37. Salvemini, D., Wang, Z. Q., Wyatt, P. S., Bourdon, D. M., Marino, M. H., Manning, P. T., Currie, M. G. (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118, 829-838.
38. Kageyama, N., Miura, M., Ichinose, M., Tomaki, M., Ishikawa, J., Ohuchi, Y., Endoh, N., Shirato, K. (1997) Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Eur. Respir. J. 10, 13-19.
39. Payá, M., Pastor, P. G., Coloma, J., Alcaraz, M. J. (1997) Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Br. J. Pharmacol. 120, 1445-1452.
40. Ferreira, H. H. A., Medeiros, M. V., Lima, C. S. P., Flores, C. A., Sannomiya, P., Antunes, E., De Nucci, G., (1996) Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. Eur. J. Pharmacol. 310, 201-207.
41. Teixeira, M. M., Williams, T. J., Hellewell, P. G. (1993) Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. 110, 1515-1521.
42. Pfeilschifter, J., Wolfgang, E., Hummel, R., Kunz, D., Mühl, H., Nitsch, D., Plüss, C., Walker, G. (1996) Therapeutic strategies for the inhibition of inducible nitric oxide synthase - potential for a novel class of anti inflammatory agents. Cell. Biol. Int. 20, 51-58.
43. Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G., Vadas, M. A. (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167, 210-224.
44. Yamagushi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Kitamura, S., Torisu, M., Mita, S., Tominaga, A., Takatsu, K., Suda, T. (1988) Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167, 1737-1742.
45. Walsh, G. M., Hartnell, A., Wardlaw, A. J., Kurihara, K., Sanderson, C. J., Kay, A. B. (1990) IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunol. 71, 258-265.
46. Coffman, R. L., Seymour, B. W. P., Hudak, S., Jackson, J., Rennick, D. (1989) Antibody to interleukin-5 inhibits helmith-induced eosinophilia in mice. Science 245, 308-310.
47. Mauser, P. J., Pitman, A., Witt, A., Fernandez, X., Zurcher, J., Kung, T., Jones, H., Watinick, A. S., Egan, R. W., Kreutner, W., Adams, G. K. (1993) Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea-pig model of asthma. Am. Rev. Respir. Dis. 148, 1623-1627.
48. Hogan, S. P., Koskinen, A., Foster, P. (1997) Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol. Cell Biol. 75, 284-288.
49. Warringa, R. A. J., Mengelers, H. J. J., Kuijper, P. H. M., Raaijmakers, J. A. M., Bruijnzeel, P. L. B., Koendermann, L. (1992) In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 79, 1836-1841.
50. Schweizer, R. C., Welmers, B. A. C., Raaijmakers, J. A. M., Zanem, P., Lammers, J. W. J., Koenderman, L. (1994) RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83, 3697-3704.
51. 111In-eosinophil accumulation in guinea-pig skin: evidence for a role for TNFα. Immunol. 84, 36-40.
52. Saito, S., Nakano, M. (1996) Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory roles of T lymphocytes and cytokines. J. Leukoc. Biol. 59, 908-915.